222 related articles for article (PubMed ID: 21859709)
41. TfR1 binding with H-ferritin nanocarrier achieves prognostic diagnosis and enhances the therapeutic efficacy in clinical gastric cancer.
Cheng X; Fan K; Wang L; Ying X; Sanders AJ; Guo T; Xing X; Zhou M; Du H; Hu Y; Ding H; Li Z; Wen X; Jiang W; Yan X; Ji J
Cell Death Dis; 2020 Feb; 11(2):92. PubMed ID: 32024821
[TBL] [Abstract][Full Text] [Related]
42. Human somatostatin receptor-3 distinctively induces apoptosis in MCF-7 and cell cycle arrest in MDA-MB-231 breast cancer cells.
War SA; Kim B; Kumar U
Mol Cell Endocrinol; 2015 Sep; 413():129-44. PubMed ID: 26112183
[TBL] [Abstract][Full Text] [Related]
43. A missense mutation in TFRC, encoding transferrin receptor 1, causes combined immunodeficiency.
Jabara HH; Boyden SE; Chou J; Ramesh N; Massaad MJ; Benson H; Bainter W; Fraulino D; Rahimov F; Sieff C; Liu ZJ; Alshemmari SH; Al-Ramadi BK; Al-Dhekri H; Arnaout R; Abu-Shukair M; Vatsayan A; Silver E; Ahuja S; Davies EG; Sola-Visner M; Ohsumi TK; Andrews NC; Notarangelo LD; Fleming MD; Al-Herz W; Kunkel LM; Geha RS
Nat Genet; 2016 Jan; 48(1):74-8. PubMed ID: 26642240
[TBL] [Abstract][Full Text] [Related]
44. PTK6 inhibition promotes apoptosis of Lapatinib-resistant Her2(+) breast cancer cells by inducing Bim.
Park SH; Ito K; Olcott W; Katsyv I; Halstead-Nussloch G; Irie HY
Breast Cancer Res; 2015 Jun; 17(1):86. PubMed ID: 26084280
[TBL] [Abstract][Full Text] [Related]
45. Hyaluronan-CD44 interaction promotes c-Src-mediated twist signaling, microRNA-10b expression, and RhoA/RhoC up-regulation, leading to Rho-kinase-associated cytoskeleton activation and breast tumor cell invasion.
Bourguignon LY; Wong G; Earle C; Krueger K; Spevak CC
J Biol Chem; 2010 Nov; 285(47):36721-35. PubMed ID: 20843787
[TBL] [Abstract][Full Text] [Related]
46. HFE modulates transferrin receptor 2 levels in hepatoma cells via interactions that differ from transferrin receptor 1-HFE interactions.
Chen J; Chloupková M; Gao J; Chapman-Arvedson TL; Enns CA
J Biol Chem; 2007 Dec; 282(51):36862-70. PubMed ID: 17956864
[TBL] [Abstract][Full Text] [Related]
47. Tyrosine phosphorylation of estradiol receptor by Src regulates its hormone-dependent nuclear export and cell cycle progression in breast cancer cells.
Castoria G; Giovannelli P; Lombardi M; De Rosa C; Giraldi T; de Falco A; Barone MV; Abbondanza C; Migliaccio A; Auricchio F
Oncogene; 2012 Nov; 31(46):4868-77. PubMed ID: 22266855
[TBL] [Abstract][Full Text] [Related]
48. Apoptosis induction in BEFV-infected Vero and MDBK cells through Src-dependent JNK activation regulates caspase-3 and mitochondria pathways.
Chen CY; Chang CY; Liu HJ; Liao MH; Chang CI; Hsu JL; Shih WL
Vet Res; 2010; 41(2):15. PubMed ID: 19846041
[TBL] [Abstract][Full Text] [Related]
49. Aplidin induces apoptosis in human cancer cells via glutathione depletion and sustained activation of the epidermal growth factor receptor, Src, JNK, and p38 MAPK.
Cuadrado A; Garcia-Fernandez LF; Gonzalez L; Suarez Y; Losada A; Alcaide V; Martinez T; Fernandez-Sousa JM; Sanchez-Puelles JM; Munoz A
J Biol Chem; 2003 Jan; 278(1):241-50. PubMed ID: 12414812
[TBL] [Abstract][Full Text] [Related]
50. ADAM15 protein amplifies focal adhesion kinase phosphorylation under genotoxic stress conditions.
Fried D; Böhm BB; Krause K; Burkhardt H
J Biol Chem; 2012 Jun; 287(25):21214-23. PubMed ID: 22544741
[TBL] [Abstract][Full Text] [Related]
51. CD44 regulates cell proliferation, migration, and invasion via modulation of c-Src transcription in human breast cancer cells.
Nam K; Oh S; Lee KM; Yoo SA; Shin I
Cell Signal; 2015 Sep; 27(9):1882-94. PubMed ID: 25979842
[TBL] [Abstract][Full Text] [Related]
52. TAE226-induced apoptosis in breast cancer cells with overexpressed Src or EGFR.
Golubovskaya VM; Virnig C; Cance WG
Mol Carcinog; 2008 Mar; 47(3):222-34. PubMed ID: 17849451
[TBL] [Abstract][Full Text] [Related]
53. Inhibition of Src activation with cardiotoxin III blocks migration and invasion of MDA-MB-231 cells.
Tsai PC; Chu CL; Chiu CC; Chang LS; Lin SR
Toxicon; 2013 Nov; 74():56-67. PubMed ID: 23933586
[TBL] [Abstract][Full Text] [Related]
54. Src tyrosine kinase inhibitor PP2 suppresses ERK1/2 activation and epidermal growth factor receptor transactivation by X-irradiation.
Li Z; Hosoi Y; Cai K; Tanno Y; Matsumoto Y; Enomoto A; Morita A; Nakagawa K; Miyagawa K
Biochem Biophys Res Commun; 2006 Mar; 341(2):363-8. PubMed ID: 16414009
[TBL] [Abstract][Full Text] [Related]
55. The Cytoplasmic domain of transferrin receptor 2 dictates its stability and response to holo-transferrin in Hep3B cells.
Chen J; Enns CA
J Biol Chem; 2007 Mar; 282(9):6201-9. PubMed ID: 17202145
[TBL] [Abstract][Full Text] [Related]
56. Effects of cell proliferation on the uptake of transferrin-bound iron by human hepatoma cells.
Lee AW; Oates PS; Trinder D
Hepatology; 2003 Oct; 38(4):967-77. PubMed ID: 14512884
[TBL] [Abstract][Full Text] [Related]
57. Src kinase phosphorylates vascular endothelial-cadherin in response to vascular endothelial growth factor: identification of tyrosine 685 as the unique target site.
Wallez Y; Cand F; Cruzalegui F; Wernstedt C; Souchelnytskyi S; Vilgrain I; Huber P
Oncogene; 2007 Feb; 26(7):1067-77. PubMed ID: 16909109
[TBL] [Abstract][Full Text] [Related]
58. Inhibition of p38-MAPK alters SRC coactivation and estrogen receptor phosphorylation.
Antoon JW; Bratton MR; Guillot LM; Wadsworth S; Salvo VA; Burow ME
Cancer Biol Ther; 2012 Sep; 13(11):1026-33. PubMed ID: 22825349
[TBL] [Abstract][Full Text] [Related]
59. Transferrin receptor 2 mediates a biphasic pattern of transferrin uptake associated with ligand delivery to multivesicular bodies.
Robb AD; Ericsson M; Wessling-Resnick M
Am J Physiol Cell Physiol; 2004 Dec; 287(6):C1769-75. PubMed ID: 15317665
[TBL] [Abstract][Full Text] [Related]
60. Transferrin receptor 1 promotes the fibroblast growth factor receptor-mediated oncogenic potential of diffused-type gastric cancer.
Shirakihara T; Yamaguchi H; Kondo T; Yashiro M; Sakai R
Oncogene; 2022 Apr; 41(18):2587-2596. PubMed ID: 35338344
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
